By your side for a healthier world™

Items in my cart

Loading your cart..

Latest Post

December 28, 2020

Particles in Injectable Drugs

A parenteral drug product contaminated by particles is a potential health threat. In the bloodstream, particles can cause serious issues, such as capillary occlusion and immunogenic responses. In most cases, the observation of particles in a drug product leads to a recall.

View Post

Lynn Yao

Manager, Scientific Affairs, CN

Particles Injectable Drug Products Packaging

Previous Posts

Cell and Gene Therapy

September 28, 2020

Overcoming the Challenge of Maintaining Sterility at Low Temperature Storage

Abbey Hisler

Director, Strategic Marketing, Biologics

Ready Pack System Gene Therapy Case Study

Patient receiving medication from doctor

August 19, 2020

How are you responding to pharmacopoeia expectation of parenteral preparations?

Victoria Morgan

Director, Global Marketing, Biologics

Oncology Lymphoma Regulatory Requirements Parenteral Packaging

AccelTRA Components Program

June 26, 2020

Performance of AccelTRA® Components

Nancy Liu

Senior Specialist, TCS, China

AccelTRA Components Risk Mitigation

Daikyo Crystal Zenith Syringe and vial and stoppers and seals

March 16, 2020

Simplify the Journey™ – Selecting Compatible Container and Delivery Systems for Protein/mAb Drugs

Ranjana Singh

Sr. Scientist, Insight Labs

Drug compatibility Drug delivery system Delivery of Drugs

March 13, 2020

Multiple Benefits of Elastomeric Closures with FluroTec® Barrier Film

Gabrielle Gehron

Associate Technical Account Specialist, TCS

FluroTec Components Elastomers Benefits

Elastomers, Stoppers and Plungers

January 06, 2020

The NovaPure® Component Portfolio – Solution for Lifecycle Management

Cathy Chhour

Sr. Technical Account Specialist, TCS, NA

NovaPure Components Vial Containment System Prefillable Systems

Load more